Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jul 15;89(14):6285-9.
doi: 10.1073/pnas.89.14.6285.

CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide

O Bagasra  1 , S D Wright, T Seshamma, J W Oakes, R J Pomerantz
Affiliations

CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide

O Bagasra et al. Proc Natl Acad Sci U S A. .

Abstract

Lipopolysaccharide (LPS) potently stimulates human immunodeficiency virus type 1 (HIV-1) long terminal repeat-directed transcription in transfected monocyte-macrophage cell lines and dramatically increases HIV-1 production in the latently infected monocyte-macrophage-like cell line U1. This response to LPS, however, can only be observed after pretreatment of the U1 cells with granulocyte-macrophage colony-stimulating factor (GM-CSF). CD14, the differentiation antigen that acts as a receptor for complexes of LPS and LPS-binding protein, is now demonstrated to be involved in LPS-induced stimulation of HIV-1 replication. CD14 is shown to be expressed on a subpopulation of U1 cells only after treatment with GM-CSF and correlates with HIV-1 production stimulated by LPS. Importantly, only those U1 cells that express CD14 can be induced by LPS to upregulate HIV-1 production. In addition, a monoclonal antibody directed against CD14 can block LPS-induced stimulation of HIV-1 production from these latently infected cells.

PubMed Disclaimer

References

    1. Am J Ophthalmol. 1989 Apr 15;107(4):361-72 - PubMed
    1. J Exp Med. 1989 Oct 1;170(4):1231-41 - PubMed
    1. Nature. 1987 Apr 16-22;326(6114):711-3 - PubMed
    1. Ann Intern Med. 1988 Mar;108(3):321-7 - PubMed
    1. J Immunol. 1988 Jul 15;141(2):547-52 - PubMed

Publication types

MeSH terms